Selective cyclooxygenase-2 inhibitors

Rheumatic Disease Clinics of North America

Volumn 25, Issue 2, 1999, Pages 359-378

  Golden, B D ^a   Abramson, S B ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; 6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NABUMETONE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN; ROFECOXIB; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; BONE; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; COLORECTAL CANCER; DRUG MECHANISM; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY; NONHUMAN; OSTEOARTHRITIS; OVARY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; RHEUMATOID ARTHRITIS; TISSUE DISTRIBUTION; UTERUS;

EID: 0033039716     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70073-9     Document Type: Article

References (144)

1. S.B. Abramson Treatment of gout and crystal arthropathies with nonsteroidal antiinflammatory drugs: Uses and mechanisms of action Curr Opin Rheumatol 4 1992 295 300
2. S.B. Abramson J. Leszczynska-Piziak K. Haines Non-steroidal anti-inflammatory drugs: Effects on a GTP binding protein within the neutrophil plasma membrane Biological Pharmacology 41 1991 1567 1573
3. S.B. Abramson G. Weissmann The mechanisms of action of nonsteroidal antiinflammatory drugs Arthritis Rheum 32 1989 1 9
4. T. Akatsu N. Takahashi N. Udagawa Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro J Bone Miner Res 6 1991 183 189
5. A.R. Amin M. Attur R.N. Patel Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage J Clin Invest 99 1997 1231 1237
6. A.R. Amin P. Vyas M. Attur The mode of action of aspirin-like drugs: Effect on inducible nitric oxide synthase Proc Natl Acad Sci USA 92 1995 7926 7930
7. G.D. Anderson S.D. Hauser K.L. McGarity Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis J Clin Invest 97 1996 2672 2679
8. M.G. Attur I.R. Patel R.N. Patel Autocrine production of IL-1β by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2 and IL-8 Proc Assoc Am Physicians 110 1998 1 8
9. A. Bennett A. Civier C.N. Hensby Measurement of arachidonate and its metabolites extracted from human normal and maligant gastrointestinal tissues Gut 28 1987 315 318
10. K.D. Brandt M. Albrecht Effect of naproxen sodium on the net synthesis of glycosaminoglycans and protein by normal canine articular cartilage in-vitro J Pharm Pharmacol 42 1990 738 740
11. J.C.S. Breitner K.A. Welsh M.J. Helms Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs Neurobiol Aging 16 1995 523 530
12. P.M. Brooks R.O. Day Nonsteroidal antiinflammatory drugs—differences and similarities N Engl J Med 324 1991 1716 1725
13. J.N. Cashman The mechanisms of action of NSAIDs in analgesia Drugs 52 suppl 5 1996 13 23
14. J. Cashman G. McAnulty Nonsteroidal anti-inflammatory drugs in perisurgical pain management Drugs 49 1995 51 70
15. A. Catania J. Arnold A. Macaluso Inhibition of acute inflammation in the periphery by central action of salicylates Proc Natl Acad Sci USA 88 1991 8544 8547
16. I. Chakraborty S.K. Das J. Wang Developmental expression of the cyclooxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids J Mol Endocrinol 16 1996 107 122
17. R.A. Copeland J.M. Williams J. Giannaras Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase Proc Natl Acad Sci USA 91 1994 11202 11206
18. L.J. Crofford COX-1 and COX-2 tissue expression: Implications and predictions J Rheumatol 24 suppl 49 1997 15 19
19. L.J. Crofford R.L. Wilder A.P. Ristimaki Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: Effects of interleukin-1B, phorbol ester, and corticosteroids J Clin Invest 93 1994 1095 1101
20. Cronstein B.N. Van de Stouwe M. L. Druska Nonsteroidal antiinflammatory agents inhibit stimulated neutrophil adhesion to endothelium: Adenosine dependent and independent mechanisms Inflammation 18 1994 323 335
21. B. Cryer M. Feldman Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs Am J Med 104 1998 413 421
22. D.L. DeWitt E.A. Meade W.L. Smith PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal antiinflammatory drugs Am J Med 95 suppl 2A 1993 40S 46S
23. F. Diaz-Gonzalez I. Gonzalez-Alvero M.R. Campanero Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs J Clin Invest 95 1995 1756 1765
24. J.A. DiBattista S. Dore N. Morin Prostaglandin E2 stimulates insulin-like growth factor binding protein-4 expression and synthesis in cultured human articular chondrocytes: Possible mediation by C (++)-calmodulin regulated processes J Cell Biochem 65 1998 408 419
25. J.A. DiBattista J.P. Martel-Pelletier M. Zafarullah Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts J Rheumatol 43 1995 123 128
26. 1 inhibit cytokine-induced metallopreotease expression in human synovial fibroblasts: Mediation by cyclic-AMP signalling pathway Lab Invest 71 1994 270 278
27. J.E. Dinchuk B.D. Car R.J. Focht Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase 2 Nature 378 1995 406 409
28. J.T. Dingle Cartilage maintenance in osteoarthritis: Interaction of cytokines, NSAID and prostaglandins in articular cartilage damage and repair J Rheumatol Suppl 28 1991 30 37
29. T. Dingle Prostaglandins in human cartilage metabolism J Lipid Mediat Cell Signal 6 1991 303 312
30. R.N. DuBois W.E. Smalley Cyclooxygenase, NSAIDs, and colorectal cancer J Gastroenterol 31 1996 898 906
31. C.E. Eberhart R.J. Coffey A. Radhika Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
32. C.E. Eberhart R.N. DuBois Eicosanoids and the gastrointestinal tract Gastroenterology 109 1995 285 301
33. E. Ehrich T. Schnitzer A. Kivitz MK-966, a highly selective COX-2 inhibitor, was effective in the treatment of osteoarthritis (OA) of the knee and hip in a 6-week placebo controlled study Arthritis Rheum 40 suppl 1997 S85
34. P. Emery Clinical implications of selective cyclooxygenase-2 inhibition Scand J Rheumatol 25 suppl 102 1996 23 28
35. D.T. Felson J.J. Anderson M. Boers Preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum 38 1995 727 735
36. H. Fenner Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles Semin Arthritis Rheum 26 suppl 1 1997 28 33
37. J.F. Fries S.R. Miler P.W. Spitz Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use Gastroenterology 96 1989 647 655
38. J.F. Fries C.A. Williams D.A. Block Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models Am J Med 91 1991 213 222
39. J.Y. Fu J.L. Masferrer K. Seibert The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes J Biol Chem 265 1990 16737 16740
40. L.A. Garcia-Rodriguez H. Jick Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs Lancet 343 1994 769 772
41. L.A. Garcia-Rodriguez Nonsteroidal antiinflammatory drugs, ulcers, and risk: A collaborative meta-analysis Semin Arthritis Rheum 26 suppl 1 1997 16 20
42. L.A. Garcia-Rodriguez C. Cattaruzzi M.G. Troncone Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other non-steroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs Arch Intern Med 158 1998 33 39
43. E. Giovannucci E.B. Rimm M.J. Stampfer Aspirin use and the risk of colorectal cancer and adenoma in male health professionals Ann Intern Med 121 1994 241 246
44. B.D. Golden The prevention and treatment of osteoporosis Arthritis Care Research 11 1998 124 134
45. B.D. Golden S.A. Abramson Toward the development of selective cox-2 inhibitors New Standards in Arthritis Care 6 1997 2 5
46. M. Goppelt-Struebe Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression Prostaglandins Leuko Essent Fatty Acids 52 1995 213 222
47. Q. Guo L.H. Wang K.H. Ruan Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents J Biol Chem 271 1996 19134 19139
48. A. Habib C. Bernard M. Kebret Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages J Immunol 158 1997 3845 3851
49. A. Habib C. Creminon Y. Frobert Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2 J Biol Chem 268 1993 23448 23454
50. R.C. Harris J.A. McKanna Y. Akai Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction J Clin Invest 94 1994 2504 2510
51. C.J. Hawkey S.A. Karrasch L. Sczenpanski Omeprazole compared with misoprostol for ulcers associated with nonsteroidal ani-inflammatory drugs N Engl J Med 338 1998 727 734
52. H.R. Herschman Regulation of prostaglandin synthase-1 and prostaglandin synthase-2 Cancer Metastasis Rev 13 1994 241 256
53. T. Hirata H. Ukawa M. Kitamura Effects of selective cyclooxygenase-2 inhibitors on alkaline secretory and mucosal ulcerogenic responses in rat duodenum Life Sci 61 1997 1603 1611
54. T. Hla K. Neilson Human cyclooxygenase-2 cDNA Proc Natl Acad Sci USA 89 1992 7384 7388
55. M.J. Holtzman V. Zhang H. Hussain Prostaglandin H synthase and lipoxygenase gene families in the epithelial cell barrier Ann NY Acad Sci 744 1994 58 77
56. R.C. Hubbard R. Koepp S.S. Yu Pilot efficacy of SC-58635, a COX-2 selective inhibitor, in rheumatoid arthritis Arthritis Rheum 40 suppl 1997 S51
57. A.A. Kalgutkar B.C. Crews W. Scott Aspirin-like molecules that covalently inactivate cyclooxygenase-2 Science 280 1998 1268 1270
58. R.Y. Kang J. Freire-Moar E. Sigal Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis Br J Rheumatol 35 1996 711 718
59. S.L. Kargman G.P. O'Neill P.J. Vickers Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer Cancer Res 55 1995 2556 2559
60. W.E. Kaufmann K.I. Andreasson P.C. Isakson Cyclooxygenases and the central nervous system Prostaglandins 54 1997 601 624
61. W.E. Kaufmann P.F. Worley J. Pegg COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex Proc Natl Acad Sci USA 93 1996 2317 2321
62. H. Kawaguchi C.C. Pilbeam J.R. Harrison The role of prostaglandins in the regulation of bone metabolism Clin Orthop 313 1995 36 46
63. E.A. Kitsis G. Weissman S.B. Abramson The prostaglandin paradox: Additive inhibition of neutrophil function by aspirin-like drugs and the prostaglandin E1 analog misoprostol J Rheumatol 18 1991 1461 1465
64. E. Kopp S. Ghosh Inhibition of NF-kB by sodium salicylate and aspirin Science 265 1994 956 959
65. D.A. Kujubu B.S. Fletcher B.C. Varnum TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue J Biol Chem 266 1991 12866 12872
66. W. Kutchera D.A. Jones N. Matsunami Prostaglandin H synthase-2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect Proc Natl Acad Sci USA 93 1996 4816 4820
67. N.E. Lane Pain management in osteoarthritis: The role of COX-2 inhibitors J Rheumatol 24 suppl 49 1997 20 24
68. R. Langenbach S.G. Morham H.F. Tiano Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration Cell 83 1995 483 492
69. F.L. Lanza D.A. Callison R.C. Hubbard A pilot endoscopic study of the gastroduodenal effects of SC-58635, a COX-2 selective inhibitor Arthritis Rheum 40 suppl 1997 S93
70. D.R. Lichtenstein S. Syngal M. Wolfe Nonsteroidal antiinflammatory drugs and the gastrointestinal tract Arthritis Rheum 38 1995 5 18
71. G.N. Lowe Y.H. Fu S. McDougal Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: Role of second messengers Endocrinology 137 1996 2208 2216
72. C. Luong A. Miller J. Barnett Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2 Nat Struct Biol 3 1996 927 933
73. J.L. Masferrer P.C. Isakson K. Seibert Cyclooxygenase-2 inhibitors: A new class of anti-inflammatory agents that spare the gastrointestinal tract Gastroenterol Clin North Am 25 1996 363 372
74. J.L. Masferrer K. Seibert B. Zweifel Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme Proc Natl Acad Sci USA 89 1992 3917 3921
75. J.L. Masferrer B.S. Zweifel P.T. Manning Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic Proc Natl Acad Sci USA 91 1994 3228 3232
76. J.L. Masferrer B.S. Zweifel K. Seibert Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice J Clin Invest 86 1990 1375 1379
77. T. Maziasz K. Seibert K. Khan Preclinical pharmacology of celecoxib and demonstration of superior safety compared with NSAIDs in dogs Arthritis Rheum 40 suppl 1997 S195
78. J.C. McGiff H.D. Itskovitz Prostaglandins and the kidney Circ Res 33 1973 479 488
79. E.A. Meade W.L. Smith D.L. DeWitt Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs J Biol Chem 268 1993 6610 6614
80. K. Mehidante R. Al-Daccack J.M. Dayer Superantigen-induced gene expression in human IFN-γ–treated fibroblast-like synoviocytes involves prostaglandin E2 J Immunol 155 1995 3570 3577
81. D.R. Mehlisch S. Mills M. Sandler Ex vivo assay of COX-2 inhibition predicts analgesic efficacy in post-surgical dental pain with MK-966 Clin Pharmacol Ther 63 PI-8 1998 139
82. L. Mengle-Gaw R.C. Hubbard A. Karim A study of the platelet effects of SC-58636, a novel COX-2 selective inhibitor Arthritis Rheum 40 suppl 1997 S93
83. J.A. Mitchell P. Akarasereenont C. Thiemermann Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase Proc Natl Acad Sci USA 90 1994 11693 11697
84. J.A. Mitchell S. Larkin T.J. Williams Cyclooxygenase-2: Regulation and relevance in inflammation Biochem Pharmacol 50 1995 1535 1542
85. S.G. Morham R. Langenbach C.D. Loftin Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse Cell 83 1995 473 482
86. P. Needleman P.C. Isakson The discovery and function of COX-2 J Rheumatol 24 suppl 49 1997 6 8
87. M.K. O'Banion H.B. Sadowski V. Winn A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein J Biol Chem 266 1991 23261 23267
88. G.P. O'Neill B.P. Kennedy J.A. Mancini Selective inhibition of COX-2 Agents Actions Suppl 46 1995 159 168
89. R.J. O'Keefe I.D. Crabb E. Puzas Influence of prostaglandins on DNA and matrix synthesis in growth plate chondrocytes J Bone Miner Res 7 1992 397 404
90. Y. Onoe C. Miyaura T. Kaminakayashiki IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2–dependent prostaglandin synthesis in osteoblasts J Immunol 156 1996 758 764
91. M.G. O'Sullivan F.H. Chilton Huggins E.M. Jr Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase J Biol Chem 267 1992 14547 14550
92. O'Sullivan M.G. Huggins E.M. Jr E.A. Meada Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages Biochem Biophys Res Commun 187 1992 1123 1127
93. P. Patrignani M.R. Panara M.G. Sciulli Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs J Physiol Pharmacol 48 1997 623 631
94. T.D. Penning J. Talley S.R. Bertenshaw Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib) J Med Chem 40 1997 1347 1365
95. D. Picot P.J. Loll R.M. Garavito The x-ray crystal structure of the membrane protein prostaglandin H2 synthase-1 Nature 367 1994 243 249
96. C.C. Pilbeam P.M. Fall C.B. Alander Differential effects of nonsteroidal anti-inflammatory drugs on constitutive and inducible prostaglandin G/H synthase in cultured bone cells J Bone Min Res 12 1997 1198 1203
97. C.C. Pilbeam H. Kawaguchi Y. Hakeda Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells J Biol Chem 268 1993 25643 25649
98. J.P. Portanova Y. Zhang G.D. Anderson Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin-6 production in vivo J Exp Med 184 1996 883 891
99. 2 on bone formation in cultured fetal rat calvariae: Role of insulin-like growth factor-I Endocrinology 133 1993 1504 1510
100. A. Raz A. Wyche P. Needleman Temporal and pharmacological division of fibroblast cyclooxygenase expression and transcriptional and translational phases Proc Natl Acad Sci USA 86 1989 1657 1661
101. A. Raz A. Wyche N. Siegel Regulation of fibroblast cyclooxygenase synthesis by interleukin-1 J Biol Chem 263 1988 3022 3028
102. D.B. Reitz J.J. Li M.B. Norton Selective cyclooxygenase inhibitors: Novel 1,2-diarylcyclopentanes are potent and orally active COX-2 inhibitors J Med Chem 37 1997 3878 3881
103. D.R. Robinson A.H. Tashijian L. Levine Prostaglandin-stimulated bone resorption by rheumatoid synovia J Clin Invest 56 1975 1181 1188
104. K.G. Saag L.M. Rubenstein E.A. Chrischilles Nonsteroidal antiinflammatory drugs and cognitive decline in the elderly J Rheumatol 22 1995 2142 2147
105. H. Sano Y. Kawahito R.L. Wilder Expression of cyclooxygenase-1 and -2 in human colorectal cancer Cancer Res 55 1995 3785 3789
106. H. Sano T. Hla J.A.M. Maier In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis J Clin Invest 89 1992 97 108
107. T. Sato I. Morita K. Sakaguchi Involvement of cyclooxygenase-2 in bone loss induced by interleukin-1B Adv Prostaglandin Thromboxane Leukot Res 23 1995 445 447
108. J.M. Scheiman NSAIDs, gastrointestinal injury, and cytoprotection Gastroenterol Clin North Am 25 1996 279 298
109. A. Schassman B.M. Peskar C. Stettler Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats Br J Pharmacol 123 1998 795 804
110. K. Seibert J. Masferrer Y. Zhang Mediation of inflammation by cyclooxygenase-2 Agents Actions Suppl 46 1995 41 50
111. K. Seibert Y. Zhang K. Leahy Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain Proc Natl Acad Sci USA 91 1994 12103 12117
112. S.J. Shiff M.I. Koutsos L. Qiao Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis Exp Cell Res 222 1996 179 188
113. I. Siegle T. Klein J.T. Backman Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue Arthritis Rheum 41 1998 122 129
114. F.E. Silverstein D.Y. Graham J.R. Senior Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs Ann Intern Med 123 1995 241 249
115. L.S. Simon Nonsteroidal antiinflammatory drugs and their effects: The importance of COX selectivity J Clin Rheumatol 2 1996 135 140
116. L.S. Simon Progress in minimizing the gastrointestinal side-effects of NSAIDs Musculoskeletal Medicine suppl Mar 1998 S5 S13
117. G. Singh R. Terry D.R. Ramey Comparative GI toxicities of NSAIDs Arthritis Rheum 41 suppl 1997 S115
118. J. Sirois J.S. Richards Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles J Biol Chem 267 1992 6382 6388
119. J.B. Smith A.L. Willis Aspirin selectively inhibits prostaglandin production in human platelets Nature 231 1971 235 239
120. W.L. Smith T.G. Bell Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex Am J Physiol 235 1978 F451 F457
121. W.L. Smith D.L. DeWitt Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs Semin Nephrol 15 1995 179 194
122. W.L. Smith E.A. Meade D.L. DeWitt Interactions of PGH synthase isozymes-1 and -2 with NSAIDs Ann NY Acad Sci 744 1994 50 57
123. W.L. Smith E.A. Meade D.L. DeWitt Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2 Ann NY Acad Sci 714 1994 136 142
124. R.S. Spangler Cyclooxygenase 1 and 2 in rheumatic disease: Implications for nonsteroidal anti-inflammatory drug therapy Semin Arthritis Rheum 26 1996 435 446
125. W.F. Stewart C. Kawas M. Corrada Risk of Alzheimer's disease and duration of NSAID use Neurology 48 1997 626 632
126. K. Subbaramaiah D. Zakim B.B. Weksler Inhibition of cyclooxygenase: A novel approach to cancer prevention Proc Soc Exp Biol Med 216 1997 201 210
127. T.A. Swierkosz J.A. Mitchell T.D. Warner Co-induction of nitric oxide synthase and cyclo-oxygenase: Interactions between nitric oxide and prostanoids Br J Pharmacol 114 1995 1335 1342
128. Y. Tanaguchi K. Yokoyama K. Inui Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide Eur J Pharmacol 330 1997 221 229
129. M.J. Thun NSAID use and decreased risk of gastrointestinal cancers Gastroenterol Clin North Am 25 1996 333 348
130. M.J. Thun M.M. Namboodiri Heath C.W. Jr Aspirin use and reduced risk of fatal colon cancer N Engl J Med 325 1991 1593 1596
131. M. Tsujii R.N. DuBois Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2 Cell 83 1995 493 501
132. J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nature 231 1971 232 235
133. J.R. Vane R.M. Botting A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2) Adv Prostaglandin Thromboxane Leukot Res 23 1995 41 48
134. J.R. Vane R.M. Botting New insights into the mode of action of antiinflammatory drugs Inflamm Res 44 1995 1 10
135. P. Vergne P. Bertin B. Liagre Differential inhibition of COX-1 and COX-2 by nonsteroidal antiinflammatory drugs in cultured synovial cells Arthritis Rheum 40 suppl 1997 S93
136. C.P. Vio C. Cespedes P. Gallardo Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells Hypertension 30 part 2 1997 687 692
137. J.C. Wiler T. DeBrouckner B. Bussel Central analgesic effect of ketoprofen in humans—electrophysiological evidence for a supraspinal mechanism in a double-blind and cross-over study Pain 38 1989 1 7
138. K.K. Wu Inducible cyclooxygenase and nitric oxide synthase Adv Pharmacol 33 1995 179 207
139. W. Xie J.G. Chipman D.L. Robertson Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing Proc Natl Acad Sci USA 88 1991 2692 2696
140. K. Yamagata K.I. Andreasson W.E. Kaufmann Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids Neuron 11 1993 371 386
141. T. Yamamoto N. Nozaki-Taguchi Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor Brain Res 739 1996 104 110
142. E. Yelin L.F. Callahan The economic cost and social and psychological impact of musculoskeletal conditions Arthritis Rheum 38 1995 1351 1362
143. C. Yokoyama T. Tanabe Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme Biochem Biophys Res Commun 165 1989 888 894
144. S.Z. Zhao H.T. Hatoum R.C. Hubbard Effect of celecoxib, a novel COX-2 inhibitor, on health-related quality of life of patients with osteoarthritis of the knee Arthritis Rheum 40 suppl 1997 S88